Older adults and frailty

Tailoring Therapy for Frail and Elderly Myeloma Patients

George T, Szalat RE

The Cancer Journal32(5)DOI: Tailoring Therapy for Frail and Elderly Myeloma PatientsPubMed: Tailoring Therapy for Frail and Elderly Myeloma Patients

Implementing geriatric assessments using the practical geriatric assessment in older adults being evaluated for cellular therapies at a safety-net hospital

Abdallah M, Fogale A, Halpin M, Szalat R, Fantasia K

Journal of Geriatric Oncology16(8):102667DOI: Implementing geriatric assessments using the practical geriatric assessment in older adults being evaluated for cellular therapies at a safety-net hospital

Clinical Characteristics, Treatment Regimens, and Survival in Elderly Patients with AL Amyloidosis

Acevedo J, Doros G, Szalat R, Sanchorawala V

Clinical Lymphoma Myeloma and Leukemia21(6):425-426DOI: Clinical Characteristics, Treatment Regimens, and Survival in Elderly Patients with AL AmyloidosisPubMed: Clinical Characteristics, Treatment Regimens, and Survival in Elderly Patients with AL Amyloidosis

Real-world one-year comparative outcomes of quadruplet and triplet induction regimens in older, transplant-ineligible multiple myeloma patients.

Cetin O, Teker G, Szalat RE

Journal of Clinical Oncology44(16_suppl):7567-7567DOI: Real-world one-year comparative outcomes of quadruplet and triplet induction regimens in older, transplant-ineligible multiple myeloma patients.

Clinical Characteristics, Treatment Regimens and Survival in Elderly Patients with AL Amyloidosis in a Tertiary Referral Center

Acevedo J, Doros G, Szalat R, Sloan JM, Sarosiek S, Sanchorawala V

Blood134(Supplement_1):5447-5447DOI: Clinical Characteristics, Treatment Regimens and Survival in Elderly Patients with AL Amyloidosis in a Tertiary Referral Center